Are you Dr. Kupfer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Takeda Pkwy
Deerfield, IL 60015Phone+1 224-554-2207
Summary
- Dr. Stuart Kupfer, MD is a pediatric endocrinologist in Deerfield, Illinois. He is currently licensed to practice medicine in Illinois.
Education & Training
- University of North Carolina HospitalsFellowship, Pediatric Endocrinology, 1989 - 1992
- Yale-New Haven Medical CenterResidency, Pediatrics, 1984 - 1987
- University of Florida College of MedicineClass of 1984
Certifications & Licensure
- IL State Medical License 2000 - 2017
Publications & Presentations
PubMed
- 27 citationsPhase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.Sidney Goldstein, Eric R. Bates, Deepak L. Bhatt, Charlie Cao, David R. Holmes
Thrombosis and Haemostasis. 2014-03-27 - 1824 citationsAlogliptin after Acute Coronary Syndrome in Patients with Type 2 DiabetesWilliam B. White, Christopher P. Cannon, Simon Heller, Steven E. Nissen, Richard M. Bergenstal
The New England Journal of Medicine. 2013-10-02 - 539 citationsHeart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trialFaiez Zannad, Christopher P. Cannon, William C. Cushman, George L. Bakris, Venu Menon
Lancet. 2015-05-23
Press Mentions
- Cytokinetics Presents Additional Data from GALACTIC-HF at the American Heart Association Scientific Sessions 2024November 16th, 2024
- Cytokinetics Presents Additional Data from GALACTIC-HF at the American Heart Association Scientific Sessions 2024November 16th, 2024
- Cytokinetics Announces Data from Phase 1 Study of CK-4021586September 9th, 2024